stockportfolio.pro
Organon & Co. P/E Ratio 2019–2025
Organon & Co. (OGN) annual price-to-earnings ratio by fiscal year, computed from SEC filings. Compound growth +13.0%/yr over 6 years.
| Fiscal year | P/E Ratio | Change (YoY) |
|---|---|---|
| FY 2025 | 9.92 | +128.0% |
| FY 2024 | 4.35 | +31.7% |
| FY 2023 | 3.30 | -50.6% |
| FY 2022 | 6.69 | +40.7% |
| FY 2021 | 4.75 | — |
| FY 2020 | — | — |
| FY 2019 | — | — |
Source: Organon & Co. SEC filings — fiscal-year-end price ÷ diluted EPS. Refreshed nightly.
See the full picture for Organon & Co.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeOrganon & Co. — frequently asked questions
What is Organon & Co.'s price-to-earnings ratio?
Organon & Co. (OGN) reported price-to-earnings ratio of 9.92 for fiscal year 2025, per its SEC filings.
How has Organon & Co.'s price-to-earnings ratio changed over time?
Between fiscal 2019 and 2025, OGN's price-to-earnings ratio grew at roughly 13.0% per year (compound annual rate), from 4.75 to 9.92.
Where does this data come from?
Figures are computed from Organon & Co.'s official SEC filings (fiscal-year-end price ÷ diluted EPS), refreshed nightly. Not investment advice.